医学
膀胱过度活动
电针
随机对照试验
冲程(发动机)
针灸科
物理疗法
生活质量(医疗保健)
麻醉
内科学
机械工程
替代医学
护理部
病理
工程类
作者
Haiyong Chen,Changde Wang,Minjie Zhou,Pui Yan Chan,Lo Lo Yam,Wing Lok Lam,Kwok-Pui Leung,Sheung-Wai Li,Wai-Yin Tsang,Bacon Fung-Leung Ng,Eric Tat-Chi Ziea,Wing‐Fai Yeung,Lixing Lao
标识
DOI:10.1177/0964528420925488
摘要
Background Although acupuncture has been shown to be effective at treating overactive bladder (OAB) following stroke, to our knowledge, no randomized controlled trial (RCT) examining the effects of acupuncture on patients with post-stroke OAB has been conducted. The aim of this preliminary study was to explore the effects of electroacupuncture (EA) in the treatment of post-stroke OAB. Methods This study was a multi-site randomized, assessor-blind, controlled pilot trial of patients with post-stroke OAB. In all, 34 post-stroke subjects (mean age: 71.0 years; 32.4% female) with OAB symptoms were randomly assigned to the treatment group or control group in a 1:1 ratio. The subjects in the treatment group were treated with six sessions of EA for 4 weeks, while the subjects in the control group received usual care. The primary outcome measure was the overactive bladder symptom scale (OABSS). Secondary outcome measures included a three day bladder diary and the stroke-specific quality-of-life scale (SSQoL). Results EA showed a moderate effect size (ES) on the perceived severity of OAB symptoms as measured by the OABSS at week 5 (one week post-treatment, ES 0.57; p = 0.034) and week 8 (three weeks post-treatment, ES 0.60; p = 0.021), although the results did not remain statistically significant after Bonferroni correction for multiple testing. No significant differences in bladder diary parameters or SSQoL score were found. The EA treatment was well tolerated by the post-stroke subjects. Conclusion A six-session EA treatment was feasible and appeared to reduce OAB symptoms in post-stroke patients. Further fully powered trials are warranted to confirm the efficacy of EA for those with post-stroke OAB.
科研通智能强力驱动
Strongly Powered by AbleSci AI